# 1. Financial Performance ## A. Key Figures * **Standalone Revenue:** **₹148 Cr** (Q2 FY'26) (+47% YoY, +33% QoQ) · **EBITDA:** **₹8.78 Cr** (Q2) · **EBITDA Margin:** **5.90%** * **Consolidated Revenue:** **₹147.49 Cr** (Q2 FY'26) (+43% YoY, +32% QoQ) · **EBITDA:** **₹9.70 Cr** (Q2) · **EBITDA Margin:** **6.59%** * Standalone PAT: **₹1.45 Cr** (Q2) vs. **(₹1.39 Cr)** loss (Q1) * **Consolidated PAT:** **₹2 Cr** (Q2) vs. **(₹47 Cr)** loss (Q1) ## B. Revenue Growth * **Strong Sequential Acceleration:** Robust year-on-year and quarter-on-quarter revenue growth across standalone and consolidated segments, driven by operating efficiency and strong demand in vertical cold-rooms, industrial refrigeration, and transport refrigeration. * **Operational Scale Driving Margins:** Standalone EBITDA margin expansion to 90% reflects significant leverage from increased scale and improved capacity utilization. ## C. Profitability Trends * **Profitability Recovery:** Sharp turnaround in profitability with both standalone and consolidated entities moving from Q1 losses to Q2 profits, signaling effective cost control and volume leverage. * **Gross Margin Pressure:** Margins softened by ~2% due to **shifts in sales mix**, notably higher contributions from quick commerce and corporate clients, though core product line performance remains intact. * **Niche Product Contribution:** Continuous panels and commercial fridges account for **15–18% of H1 revenue**, but are not primary drivers of margin variability. ## D. EBITDA Margin * **Margin Guidance Raised:** Management expects EBITDA margin to reach **at least 8%** in H2, supported by scale benefits and **1% price increase**—the first in 2–3 years—marking a shift from growth-at-all-costs to margin-conscious pricing. * **Pricing Power Reasserted:** The planned price hike underscores improved market positioning and confidence in demand resilience after a prolonged period of frozen pricing. ## E. Balance Sheet * **Balance Sheet Strengthening:** Strategic focus on prudent financial management to fortify the balance sheet and fund future expansion organically. --- # 2. Order Book & Demand ## A. Key Figures * **Order Book:** **₹190 Cr** (ongoing pipeline) · **₹650 Cr** full-year revenue target (40:60 H1:H2 split) * **Margin Benefit:** **1%** full-year uplift expected from phased price increases ## B. Current Order Book * **Diversified Pipeline:** Order book spans multiple segments with **ammonia vertical (₹52 Cr)** and **project orders (₹45 Cr)** as largest components, indicating strong project execution momentum. * **Execution Tempo:** Average delivery cycle of **45 days**, though complex projects extend to six months, reflecting scalability in fulfillment capacity. * **Demand-Supply Alignment:** Management views rising competition—including from **Varun Beverages**—as accommodated by expanding cold chain demand, particularly in **freezers and vici coolers**, supporting sustainable growth. ## C. Customer Mix & Competitive Landscape * **Upgraded Mix:** Increasing sales to **corporate and retail segments** signal improved customer quality and pricing power. * **Segmented Competition:** Competitive dynamics vary by vertical—**Kingspan, Jindal, Metecno** in continuous panels; **Blue Star, Voltas, Carrier** in commercial refrigeration; **Suraksha, Sub-Zero** in transport; and **Rinac, Freak** in ammonia systems. --- # 3. Product & Segment Performance ## A. Key Figures * **Revenue Mix:** **49%** cold room · **15–16%** old commercial vertical · **10%** continuous panel · **7%** ammonia · **6–7%** commercial freezer · **5%** transport refrigeration · **4%** project business · **3%** industrial refrigeration * **New Sectors Contribution:** **21%** of H1 FY'26 revenue * Chest Freezer Orders: ₹1 Cr (current order book) ## B. Cold Room Sales * **Dominant Segment:** Cold rooms remain the largest revenue driver, with **strong double-digit growth** fueled by expanding demand from food processing, dairies, pharma, and healthcare end markets. * **Product Mix Stability:** Revenue distribution across segments remains consistent, with cold rooms nearly half of total sales, reflecting entrenched market positioning. ## C. New Verticals * **Strategic Expansion:** New verticals now contribute a **meaningful 21% of revenue**, driven by tailored, energy-efficient solutions for agriculture, pharma, and big commerce sectors. * **Path to Profitability:** New business lines on track to reach **break-even this fiscal year**, with anticipated positive EBITDA margin contribution despite current lack of segment-level profitability tracking. * **Early-Stage Momentum:** Chest freezer division shows initial traction, with order ramp-up expected post-November as commercialization accelerates. --- # 4. Geography & Channel Mix ## A. Key Figures * **Revenue Mix:** **50%** West · **16%** North · **16%** South · **12%** East · **3%** exports · **2%** national dealers/OEMs ## B. Regional Revenue * **Core Concentration, Balanced Expansion:** Revenue remains concentrated in the West, but strategic momentum builds in the Eastern, Central, and Southern regions across 20 active projects. * **Demand Shift:** Rising inquiries for **energy-efficient, eco-friendly refrigeration technologies** signal a shift toward sustainable solutions and potential long-term structural demand. * **East Region Context:** Prior H1 strength in the East was skewed by a **single large project**, indicating current 12% contribution is more representative of baseline demand. --- # 5. Capacity & CAPEX ## A. Key Figures * **Production Capacity:** **₹550 Cr** (old business) * **Revenue Target:** **₹500 Cr** (old business) * **CAPEX Incurred (H1 FY26):** **₹22 Cr** (includes carryover and initial Phase II spend) * **Land Cost (Phase II):** **₹5 Cr** of planned **₹150 Cr** CAPEX * **H2 CAPEX Guidance:** **₹3–5 Cr** (base case), up to **₹15 Cr** if additional developments proceed ## B. Production Capacity * **Capacity Utilization Focus:** Growth strategy centers on full capacity utilization, automation, and technology upgradation to drive efficiency. * **Inventory Build-Up Pattern:** Off-season inventory accumulation in **WIP and finished goods** contributes to seasonally elevated inventory levels. ## C. Phase II CAPEX * **Phase II Status:** ₹150 Cr expansion remains under active discussion, described as progressing positively but not yet finalized. * **Funding Approach:** Expected to leverage **remaining debt capacity** and may include **equity financing**, with structure to be determined. * **Execution Progress:** Initial steps underway, including land acquisition; minimal spend expected in H2 unless scope expands. --- # 6. Risks & Capital Efficiency ## A. ROCE Pressure * **ROCE Under Pressure:** Return on capital employed faces headwinds from rising debt, potential equity dilution, stretched working capital, and margin challenges. * **Near-Term Drag:** Current-year ROCE will be impacted by partial-year contribution from the new plant, with full-cycle benefits expected only after the upcoming season. * **Funding Flexibility:** Management retains optionality for **equity funding** as projects advance, despite a debt-to-equity ratio above 1. ## B. Working Capital * **Strategic Inventory Build:** Working capital stretched due to proactive stockpiling of **compressors and raw materials** to mitigate BIS-related supply disruptions for chest freezers. * **Model Shift Impact:** Elevated inventory and debtor days reflect expansion into **new business segments** and transition to a **regular distributor model in PUF**. * **H2 Recovery Expected:** A **drastic improvement in the working capital cycle** is anticipated in the second half, supported by stronger sales and a more favorable business mix. --- # 7. Guidance & Outlook ## A. Key Figures * **Revenue Target:** **₹1,000 Cr** by FY'28 * **EBITDA Margin Guidance:** **10–11%** by FY'28 (CAPEX-dependent) * **FY'26 EBITDA Margin:** **8%** full-year forecast vs. ~5% in H1 * **CAPEX Plan:** **₹150 Cr** planned for capacity expansion * **Long-term ROCE Target:** **~25%**, expected post-ramp-up ## B. Revenue Target * **H2-Dominated Seasonality:** Business historically weighted toward second half, with **60% of annual volume** typically realized post-Q2, supporting back-end loaded revenue and margin delivery. * **Milestone Trajectory:** ₹1,000 Cr revenue target by FY'28 reflects disciplined scaling, contingent on successful CAPEX execution and volume ramp-up. ## C. Margin Forecast * **Margin Recovery Path:** Full-year EBITDA margin forecast at 8% despite weak H1, driven by **seasonal mix shift** and expected Q4 strength, consistent with prior-year patterns. * **Near-Term Pressure, Medium-Term Lift:** Margins may dip slightly this year due to new vertical ramp-up costs, but **next-year margin expansion** is anticipated as these businesses scale. * **Gross Margin Stabilization:** Corporate-retail sales mix normalization expected by year-end, supporting margin predictability. ## D. Long-term ROCE * **ROCE Lag Behind Margins:** While EBITDA margins are on track to meet targets, **ROCE may be delayed by 1–2 years** due to ramp-up time for new CAPEX and suboptimal initial utilization. * **ROCE Rebound Case:** Return to **20–25% ROCE range** expected once ₹1,000 Cr+ revenue and target EBITDA margins are achieved and new plant reaches full efficiency.